Eva-katrine K. Aarnes
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Prostate cancer radiogenomics reveals proliferative gene expression programs associated with distinct MRI-based hypoxia levels.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 15, 2023
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
Journal: Molecular oncology
Published: August 13, 2021
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer.
Journal: American journal of nuclear medicine and molecular imaging
Published: March 17, 2021
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity.
Journal: EBioMedicine
Published: March 23, 2020
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 27, 2019
Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers.
Journal: Translational oncology
Published: October 25, 2018
Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 10, 2018
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 25, 2015
Last Updated: 09/26/2026